BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9305364)

  • 1. Homozygotes and heterozygotes for ciliary neurotrophic factor null alleles do not show earlier onset of Huntington's disease.
    Rubinsztein DC; Leggo J; Chiano M; Korn S; Dodge A; Norbury G; Rosser E; Craufurd D
    Neurology; 1997 Sep; 49(3):890-2. PubMed ID: 9305364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
    Emerich DF; Bruhn S; Chu Y; Kordower JH
    Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations of homozygote allele carriers in Huntington disease.
    Cubo E; Martinez-Horta SI; Santalo FS; Descalls AM; Calvo S; Gil-Polo C; Muñoz I; Llano K; Mariscal N; Diaz D; Gutierrez A; Aguado L; Ramos-Arroyo MA;
    Neurology; 2019 Apr; 92(18):e2101-e2108. PubMed ID: 30867264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
    Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
    Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
    Denovan-Wright EM; Attis M; Rodriguez-Lebron E; Mandel RJ
    J Neurosci Res; 2008 Jun; 86(8):1748-57. PubMed ID: 18293418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice.
    Zala D; Bensadoun JC; Pereira de Almeida L; Leavitt BR; Gutekunst CA; Aebischer P; Hayden MR; Déglon N
    Exp Neurol; 2004 Jan; 185(1):26-35. PubMed ID: 14697316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis.
    Orrell RW; King AW; Lane RJ; de Belleroche JS
    J Neurol Sci; 1995 Oct; 132(2):126-8. PubMed ID: 8543936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
    Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
    Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
    Menalled LB; Kudwa AE; Miller S; Fitzpatrick J; Watson-Johnson J; Keating N; Ruiz M; Mushlin R; Alosio W; McConnell K; Connor D; Murphy C; Oakeshott S; Kwan M; Beltran J; Ghavami A; Brunner D; Park LC; Ramboz S; Howland D
    PLoS One; 2012; 7(12):e49838. PubMed ID: 23284626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminology.
    Uhlmann WR; Peñaherrera MS; Robinson WP; Milunsky JM; Nicholson JM; Albin RL
    Am J Med Genet A; 2015 May; 167A(5):1152-60. PubMed ID: 25736541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
    Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
    Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease.
    Anderson KD; Panayotatos N; Corcoran TL; Lindsay RM; Wiegand SJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7346-51. PubMed ID: 8692996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
    Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
    J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic analysis of Turkish patients with Huntington's disease.
    Ataç FB; Elibol B; Schaefer F
    Acta Neurol Scand; 1999 Sep; 100(3):195-8. PubMed ID: 10478585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.
    Mittoux V; Joseph JM; Conde F; Palfi S; Dautry C; Poyot T; Bloch J; Deglon N; Ouary S; Nimchinsky EA; Brouillet E; Hof PR; Peschanski M; Aebischer P; Hantraye P
    Hum Gene Ther; 2000 May; 11(8):1177-87. PubMed ID: 10834619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
    Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
    J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
    Régulier E; Pereira de Almeida L; Sommer B; Aebischer P; Déglon N
    Hum Gene Ther; 2002 Nov; 13(16):1981-90. PubMed ID: 12427308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA haplotype analysis of CAG repeat in Taiwanese Huntington's disease patients.
    Wang CK; Wu YR; Hwu WL; Chen CM; Ro LS; Chen ST; Gwinn-Hardy K; Yang CC; Wu RM; Chen TF; Wang HC; Chao MC; Chiu MJ; Lu CJ; Lee-Chen GJ
    Eur Neurol; 2004; 52(2):96-100. PubMed ID: 15273431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?
    Kordower JH; Isacson O; Emerich DF
    Exp Neurol; 1999 Sep; 159(1):4-20. PubMed ID: 10486171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.